Accessibility navigation

PEGylated systems in pharmaceutics

Porfiryeva, N. N., Moustafine, R. I. and Khutoryanskiy, V. V. ORCID: (2020) PEGylated systems in pharmaceutics. Polymer Science Series C, 61 (1). pp. 62-74. ISSN 1811-2382

Text - Accepted Version
· Please see our End User Agreement before downloading.


It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1134/S181123822001004X


This review addresses the use of poly(ethylene glycol) (PEG) and PEG conjugation for the design of novel dosage forms and the modification of biomolecules. The peculiarities of PEGylated nanoparticles, liposomes, proteins, enzymes, and small drug and polyelectrolyte molecules and their influence on systemic drug delivery, including overcoming of various biological barriers and adhesion to mucosal tissues (mucoadhesion), are considered.

Item Type:Article
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmaceutics Research Group
ID Code:91652


Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation